Richard Bihrle

Author PubWeight™ 26.27‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Short-term morbidity of primary retroperitoneal lymph node dissection in a contemporary group of patients. J Urol 2007 1.53
2 Incidence, histology and management of intraluminal thrombus at post-chemotherapy retroperitoneal lymph node dissection. J Urol 2013 1.48
3 Ventral onlay buccal mucosa urethroplasty: a 10-year experience. Int J Urol 2013 1.40
4 Use of ileum as ureteral replacement in urological reconstruction. J Urol 2008 1.22
5 Long-term outcome for patients with high volume retroperitoneal teratoma undergoing post-chemotherapy surgery. J Urol 2009 1.07
6 Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer. J Urol 2002 1.05
7 Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor? Cancer 2007 1.04
8 The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy. J Clin Oncol 2005 1.02
9 Histology in mixed germ cell tumors. Is there a favorite pairing? J Urol 2004 0.96
10 Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection. J Clin Oncol 2005 0.95
11 Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity? J Urol 2003 0.93
12 Does retroperitoneal lymph node dissection have a curative role for patients with sex cord-stromal testicular tumors? Cancer 2003 0.93
13 Bilateral testicular epidermoid cysts managed by partial orchiectomy. J Urol 2002 0.91
14 Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer. J Urol 2004 0.90
15 Early catheter removal after radical retropubic prostatectomy: long-term followup. J Urol 2003 0.89
16 Current status of retroperitoneal lymph node dissection and testicular cancer: when to operate. Cancer Control 2002 0.88
17 Serum tumor markers in testicular cancer. Urol Oncol 2010 0.85
18 Anatomic distribution of periprostatic adipose tissue: a mapping study of 100 radical prostatectomy specimens. Cancer 2003 0.85
19 Results of retroperitoneal lymph node dissection after chemotherapy in patients with pure seminoma in the orchidectomy specimen but elevated serum alpha-fetoprotein. BJU Int 2009 0.80
20 Clinical and pathological features predictive of nephrectomy at post-chemotherapy retroperitoneal lymph node dissection. J Urol 2012 0.79
21 Impact of the number of positive lymph nodes on disease-free survival in patients with pathological stage B1 nonseminomatous germ cell tumor. J Urol 2005 0.79
22 Ejaculatory status and fertility rates after primary retroperitoneal lymph node dissection. J Urol 2010 0.79
23 Nephrectomy for metastatic renal cell carcinoma: Indiana University experience. Urology 2003 0.79
24 Pathologic findings and therapeutic outcome of desperation post-chemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer. Urol Oncol 2005 0.79
25 Does the histology of nodal metastasis predict systemic relapse after retroperitoneal lymph node dissection in pathological stage B1 germ cell tumors? J Urol 2005 0.79
26 Is it necessary to separate clinical stage T1c from T2 prostate adenocarcinoma? BJU Int 2005 0.78
27 Post chemotherapy RPLND in patients with elevated markers: current concepts and clinical outcome. Urol Clin North Am 2007 0.77
28 Is retroperitoneal histology predictive of liver histology at concurrent post-chemotherapy retroperitoneal lymph node dissection and hepatic resection? J Urol 2010 0.77
29 Radical prostatectomy as initial monotherapy for patients with pathologically confirmed high-grade prostate cancer. BJU Int 2009 0.76
30 Percutaneous imaging-guided access for the treatment of calculi in continent urinary reservoirs. Cardiovasc Intervent Radiol 2002 0.75
31 Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors. Urology 2007 0.75
32 Three-tiered nodal classification system for bladder cancer: a new proposal. Future Oncol 2015 0.75
33 Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy? J Urol 2007 0.75
34 Division of prostatic anterior fibromuscular stroma reduces urethral resistance in an ex vivo human prostate model. Urology 2010 0.75
35 Delayed orchiectomy at postchemotherapy retroperitoneal lymph node dissection due to laterality of retroperitoneal metastatic pattern consistent with testicular primary: assessment of pathologic findings. Urology 2008 0.75
36 Secondary surgery in germ cell tumors--when and how extensively should it be performed? World J Urol 2004 0.75
37 Role of routine stentograms following urinary diversion in modern practice. Can J Urol 2009 0.75